GT Biopharma gains FDA nod for cancer trial - Investing.com

Retrieved on: 2024-06-27 19:26:33

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma gains FDA nod for cancer trial - Investing.com. View article details on hiswai:

Excerpt

GTB-3650, part of GT Biopharma's TriKE® platform, targets natural killer (NK) cells to potentially improve treatment outcomes over current AML ...

Article found on: www.investing.com